Brief: Neurosense Therapeutics - Positive Results Align With Co's Regulatory Strategy, Reinforce Long-Term Safety Profile Of Drug Candidate Primec

Neurosense Therapeutics

09/09/2024 11:25

Sept 9 (Reuters) - Neurosense Therapeutics Ltd  NRSN.O :
    * NEUROSENSE THERAPEUTICS - POSITIVE RESULTS ALIGN WITH CO'
S
REGULATORY STRATEGY, REINFORCE LONG-TERM SAFETY PROFILE OF DRUG
CANDIDATE PRIMEC

Source text for Eikon:  ID:n0001213900-24-076685 
Further company coverage:  NRSN.O 

 ((Reuters.Briefs@thomsonreuters.com;))